6 alpha mercaptopurine sensitivity
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
|
0 |
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of blood and blood-forming tissues
|
disease |
|
Finding
|
23
|
1
|
0.100 |
None |
|
0 |
|
|
|
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Gastrointestinal irritation
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
< 0.001 |
1 |
|
1995 |
1995 |
Spondylarthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
158
|
23
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Lymphoid leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
288
|
4
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Uremia
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
110
|
2
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Nausea and vomiting
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
257
|
11
|
0.010 |
None |
< 0.001 |
1 |
|
2004 |
2004 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2005 |
Immunosuppression
|
disease |
|
Disease or Syndrome
|
632
|
9
|
0.020 |
None |
1.000 |
2 |
|
1995 |
2005 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2005 |
Hyperplasia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
131
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Venoocclusive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
34
|
4
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Viral hepatitis
|
group |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
79
|
5
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Liver diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1019
|
100
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Diffuse alveolar hemorrhage
|
disease |
|
Disease or Syndrome
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
478
|
667
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Agranulocytosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
55
|
8
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2009 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2009 |
HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Rheumatism
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
197
|
19
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
847
|
94
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |